We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MYRG:NASDAQMYR Group, Inc. Analysis

Data as of 2026-04-19 - not real-time

$329.33

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

MYR Group is trading near its 52‑week high with the short‑term moving average comfortably above the longer‑term average, and the MACD line sitting above its signal, indicating bullish momentum. However, the RSI has climbed into overbought territory and the stock’s beta of well above 1.5 together with a 30‑day volatility exceeding 40% signal heightened price swings. Recent news of a price jump following the U.S.–Iran cease‑fire agreement shows the stock’s sensitivity to geopolitical headlines, adding short‑term upside potential but also reinforcing the overbought bias.
Fundamentally, the company is delivering strong top‑line growth of roughly 17% YoY, solid cash generation, and a very low debt‑to‑equity profile, positioning it well to capture secular demand for grid upgrades and electric‑vehicle charging infrastructure. Yet a trailing P/E near 44 versus an industry average of 31, and a DCF‑derived fair value that still places the current price modestly above intrinsic worth, suggest that the stock is currently overvalued. The absence of a dividend further underscores its growth‑oriented profile.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD but RSI in overbought zone
  • Price near resistance and 52‑week high
  • Geopolitical news‑driven volatility

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Sustained revenue growth and strong cash flow
  • High valuation relative to peers
  • Low leverage and ample liquidity

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Secular demand for grid modernization and EV charging infrastructure
  • Robust balance sheet with low debt
  • Potential valuation correction toward DCF fair value

Key Metrics & Analysis

Financial Health

Revenue Growth17.30%
Profit Margin3.24%
P/E Ratio43.7
ROE18.79%
ROA6.49%
Debt/Equity15.67
P/B Ratio7.7
Op. Cash Flow$326.6M
Free Cash Flow$231.2M
Industry P/E31.3

Technical Analysis

TrendBullish
RSI71.1
Support$257.25
Resistance$331.28
MA 20$294.38
MA 50$279.16
MA 200$226.18
MACDBullish
VolumeStable
Fear & Greed Index90.21

Valuation

Fair Value$413.41
Target Price$307.00
Upside/Downside-6.78%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta1.67
Volatility46.31%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.